MedTrace Logo

Multi-Gyn FloraFem Study for Treatment of Vulvo Vaginal Candidiasis Symptoms

NCT05552378 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-06-01

No results posted yet for this study

Summary

Women diagnosed with Vulvovaginal Candidiasis by the health care professional will be enrolled in the study. All participants should fulfil inclusion and exclusion criteria.

The study product will be used for 5 days, once a day. The doctor will evaluate the patients before and at the end of the treatment.

Conditions

  • Vulvovaginal Candidiasis

Interventions

DEVICE

Multi-Gyn FloraFem

Vaginal gel packed in 5 single use plastic tubes.

Sponsors & Collaborators

  • Karo Pharma AB

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-20
Primary Completion
2023-03-30
Completion
2023-04-05

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05552378 on ClinicalTrials.gov